M. J. Devesa

A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

Sonia Alonso López, María Luisa Manzano, Francisco Gea et al. · Hepatology · 2020 · 96 citations

Medicine, Oncology, Hepatology +16

Polymorphism of the <i>TLR4</i> Gene Reduces the Risk of Hepatitis C Virus-Induced Hepatocellular Carcinoma

José A. G. Agúndez, Elena García‐Martín, M. J. Devesa et al. · Oncology · 2012 · 56 citations

Life Sciences, Genetics, Immunology +17

Vitamin D deficiency and vitamin D therapy in chronic hepatitis C

José M. Ladero, María José Torrejón, Pilar Cubiles Sánchez-Pobre et al. · Annals of Hepatology · 2013 · 51 citations · Full text

Medicine, Infectious Diseases, Nutritional Sciences +17

Effectiveness and safety of sofosbuvir‐based regimens plus an <scp>NS</scp>5A inhibitor for patients with <scp>HCV</scp> genotype 3 infection and cirrhosis. Results of a multicenter real‐life cohort

Mar Riveiro‐Barciela, Inmaculada Fernández, Diego Rincón et al. · Journal of Viral Hepatitis · 2016 · 42 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (<scp>HCV</scp>) infection in patients with severe renal impairment: A multicentre experience

Raquel Muñoz-Gómez, Diego Rincón, Adriana Ahumada et al. · Journal of Viral Hepatitis · 2016 · 42 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17